Senores Pharmaceuticals | Business Upturn

Latest Articles

Senores Pharmaceuticals shares jump over 4% following U.S. launch of Deferiprone Tablets USP, 500 mg & 1000

Stock Market · Dec 12, 2025

blank

Senores Pharmaceuticals launches Deferiprone Tablets USP, 500 mg & 1000 mg in the U.S. market

Corporates · Dec 11, 2025

blank

Senores Pharmaceuticals acquires USFDA-approved ANDA for Enalapril Maleate Tablets from Wockhardt

Corporates · May 20, 2025

blank

Senores Pharmaceuticals acquires USFDA-approved ANDA for Tramadol Tablets from APDM Pharmaceuticals

Corporates · May 9, 2025

blank

Senores Pharmaceuticals share price jumps 3% after company acquires ANDA for Topiramate tablets from Wockhardt

Stock Market · May 6, 2025

blank

Senores Pharmaceuticals acquires ANDA for Topiramate tablets from Wockhardt

Corporates · May 5, 2025

blank

Senores Pharmaceuticals commences operations at new Greenfield API facility in Rajpur

Corporates · Feb 26, 2025

blank

Senores Pharmaceuticals acquires ANDA for Roflumilast tablets from Breckenridge Pharmaceutical

Corporates · Feb 20, 2025

blank

Senores Pharmaceuticals shares jump over 8% post Q3 FY25 results announcement

Stock Market · Jan 23, 2025

By Aditya Bhagchandani

blank

Senores Pharmaceuticals Q3 FY25 Results: Revenue up 31% YoY to Rs 103.02 crore, Net Profit up 131% YoY

Corporates · Jan 23, 2025

By Aditya Bhagchandani

blank

Senores Pharmaceuticals receives USFDA approval for Metoprolol Tartrate and Hydrochlorothiazide tablets

Corporates · Jan 9, 2025

By Aditya Bhagchandani

blank

Senores Pharmaceuticals shares debut with 53.5% gains, listing at Rs 600 on NSE

IPO · Dec 30, 2024

By Aditya Bhagchandani

blank

Senores Pharmaceuticals IPO: Key details, subscription status, and GMP update

IPO · Dec 23, 2024

By Aditya Bhagchandani